Zecyte 250 MG Tablet contains Abiraterone Acetate 250mg, providing the same CYP17A1 inhibition mechanism as branded abiraterone products in a cost-effective generic formulation for prostate cancer therapy.

How It Works: Abiraterone blocks CYP17A1 (17α-hydroxylase/C17,20-lyase), a key enzyme in androgen biosynthesis, dramatically reducing circulating testosterone to near-undetectable levels.

Common Uses: Metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer in combination with androgen deprivation therapy.

Administration: Must be taken on an empty stomach. No food for at least 2 hours before and 1 hour after the dose. Administer alongside prednisone as directed by your oncologist.

Storage: Store below 30°C in dry conditions. Keep in original packaging away from children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.